Cargando…
Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review
The COVID-19 pandemic, caused by SARS-CoV-2, continues to impact global health regarding both morbidity and mortality. Although SARS-CoV-2 primarily causes acute respiratory distress syndrome (ARDS), the virus interacts with and influences other organs and tissues, including blood vessel endothelium...
Autores principales: | Morowitz, Jeremy M., Pogson, Kaylyn B., Roque, Daniel A., Church, Frank C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139310/ https://www.ncbi.nlm.nih.gov/pubmed/35624923 http://dx.doi.org/10.3390/brainsci12050536 |
Ejemplares similares
-
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2
por: Butterworth, Roger F.
Publicado: (2023) -
Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular System
por: Randhawa, Puneet Kaur, et al.
Publicado: (2020) -
Reply to: SARS‐CoV‐2 as a Potential Trigger of Neurodegenerative Diseases
por: Outeiro, Tiago F., et al.
Publicado: (2020) -
Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS
por: Szabo, Marcell P., et al.
Publicado: (2022) -
Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
por: Huber, Meret K., et al.
Publicado: (2021)